FilingSEC EDGAR8-K
MetaVia Appoints Sarah Kaplan Browne, M.D. as Chief Medical Officer
· SEC accepted
StageClinical-stage
Filing content
The company appointed clinical development expert Sarah Kaplan Browne, M.D. as Chief Medical Officer to lead the development of its cardiometabolic pipeline, including DA-1726.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…